Cohance Lifesciences Ltd share price logo

Cohance Lifesciences Ltd

NSE: COHANCE

BSE: 543064

Small Cap

Pharma Sector

₹479.25

+15.70

(+3.39%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Cohance Lifesciences shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Among the most traded stocks

339th

Cohance Lifesciences was the 339th most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

20 days

INDmoney investors hold Cohance Lifesciences shares for an average of 20 days.

Key Events for Cohance Lifesciences

Last Dividend Declared

₹5.00 per share, declared on 02/09/2022

View Dividend History

Cohance Lifesciences Stock Performance

as on October 27, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹460.55
    ₹483.70
    downward going graph

    3.90%

    Downside

    0.93%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹266.70
    ₹903.40
    downward going graph

    44.35%

    Downside

    88.50%

    Upside

    downward going graph

Cohance Lifesciences share price movements today

Previous Close
₹463.55
Open
₹463.00
Volume
12.28L
Upper Circuit
₹556.25
Lower Circuit
₹370.85
Day's Low - High
₹460.55 - ₹483.70
52 Week Low - High
₹266.70 - ₹903.40

Cohance Lifesciences Historical Returns

1 Month Return
+ 2.26 %
3 Month Return
+ 8.31 %
1 Year Return
-45.49 %
3 Year Return
-18.44 %
5 Year Return
-9.13 %

Cohance Lifesciences Fundamentals

as on October 27, 2026 at 4:01 pm IST

Market Cap

₹17,735.30 Cr

Return on Equity (ROE)

5.23

PE Ratio (TTM)

166.74

Return on capital employed (ROCE)

7.31

Industry PE ratio

48.9

Beta (LTM)

0.86

P/B Ratio

2.58

Dividend Yield

0

PEG Ratio

-17.91

Quarterly Earnings Growth YOY

-197.39

EPS (TTM)

3.92

Book Value

102.23

Cohance Lifesciences Stock Valuation

as on October 27, 2026 at 4:01 pm IST

Cohance Lifesciences in the last 5 years

  • Overview

  • Trends

Lowest (4.48x)

March 30, 2020

Industry (48.90x)

October 26, 2026

Today (166.74x)

October 26, 2026

Highest (171.06x)

August 20, 2026

LowHigh

Today’s Price to Earnings Ratio: 166.74x

Cohance Lifesciences Technical Analysis

Track how Cohance Lifesciences technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish1
Bullish13
Neutral1

Oscillators

Name

Value

Action

MACD level (12,26)
2.5
Bullish
CCI (20)
-63.64
Neutral
RSI (14)
70.83
Bearish
Momentum (10)
4.15
Bullish
ADI (14)
50.73
Bullish
Ultimate Oscillator (7,14,28)
82.2
Bullish

Moving Averages

Name

Value

Action

SMA (20)
478.55
Bullish
EMA (20)
478.85
Bullish
VWMA (20)
480.11
Bullish
SMA (50)
474.06
Bullish
EMA (50)
475.94
Bullish
SMA (200)
474.57
Bullish
EMA (200)
473.89
Bullish
KAMA (200)
477
Bullish
DEMA (200)
476.33
Bullish

Cohance Lifesciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cohance Lifesciences with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
HOLD17,735.30-1.83%0.621502,268
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY14,926.4111.2%0.733978,279
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
NA5,789.47-6.99%0.661,5531,879
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY11,802.0431.62%0.682811,703
Poly Medicure Ltd image
Poly Medicure Ltd
BUY14,631.5311.74%0.573201,875
See all

Market expectation of Cohance Lifesciences Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

HOLD

37.50%

Buy

12.50%

Hold

50.00%

Sell

Cohance Lifesciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
219.82
252.93
488.08
603.77
676.23
840.42
549.31
555.57
544.55
619.12
422.26
Other Income
14.34
17.05
19.41
16.19
21.56
12.05
14.17
15.6
6.16
-1.84
12.25
Total Income
234.16
269.98
507.49
619.96
697.79
852.47
563.48
571.17
550.71
617.28
434.51
Expenses
153.74
179.59
362.98
398.4
438.86
626.98
445.4
434.62
454.06
536.95
421.1
Operating Profit
66.08
73.34
125.1
205.37
237.37
213.44
103.91
120.95
90.49
82.17
1.16
Operating Profit Margin %
30.06%
29%
25.63%
34.01%
35.1%
25.4%
18.92%
21.77%
16.62%
13.27%
0.27%
Profit Before Interest, Tax and Depreciation
80.42
90.4
144.51
221.56
258.93
225.49
118.08
136.55
96.65
80.33
13.41
Interest
2.16
2.3
10.2
9.61
10.8
10.45
10.18
8.76
9.11
9.19
6.74
Depreciation
12.79
17.25
31.28
37.79
43.56
54.17
45.14
44.02
46.94
51.23
49.54
Profit Before Tax
65.47
70.85
103.03
174.16
204.57
160.87
62.76
83.77
40.6
19.91
-42.87
Tax Paid
18.72
17.48
27.66
35.92
51.09
43.72
16.36
17.38
11.58
11.6
2.32
Profit After Tax
46.75
53.37
75.37
138.24
153.48
117.15
46.4
66.39
29.02
8.31
-45.19
Total Net profit including share of profit / Loss from associate company
46.75
53.37
75.37
138.24
153.48
117.15
46.4
66.39
29.02
8.31
-45.19
EPS
1.84
2.1
1.98
3.63
4.02
3.16
1.28
1.94
0.96
0.51
-0.63
Actual EPS
1.84
2.1
1.98
3.63
4.02
3.16
1.28
1.94
0.96
0.51
-0.63
Adjusted EPS
1.84
2.1
1.98
3.63
4.02
3.16
1.28
1.94
0.96
0.51
-0.63
Diluted EPS
1.84
2.1
1.97
3.61
4.01
3.1
1.27
1.93
0.96
0.5
-0.65

Cohance Lifesciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
377.83
833.79
1,009.72
1,320.22
1,340.33
1,051.35
2,608.5
2,268.55
Other Income
0.6
66.33
67.97
133.49
46.36
61.91
69.21
34.09
Total Income
378.43
900.12
1,077.69
1,453.71
1,386.69
1,113.26
2,677.71
2,302.64
Expenses
206.28
452.19
569.24
740.8
766.17
645.54
1,827.22
1,871.03
Operating Profit
171.55
381.6
440.48
579.42
574.16
405.81
781.28
397.52
Operating Profit Margin %
45.4%
45.77%
43.62%
43.89%
42.84%
38.6%
29.95%
17.52%
Profit Before Interest, Tax and Depreciation
172.15
447.93
508.45
712.92
620.53
467.72
850.49
431.61
Interest
2.79
19.92
9.14
6.23
12.81
7.45
41.06
37.24
Depreciation
11.5
23.51
31.64
39.1
47.99
54.6
166.8
187.33
Profit Before Tax
157.86
404.5
467.67
667.59
559.73
405.67
642.63
207.04
Tax Paid
48.59
87.51
105.34
213.78
148.44
105.39
158.39
56.92
Profit After Tax
109.27
317
362.34
453.8
411.29
300.28
484.24
150.12
Total Net profit including share of profit / Loss from associate company
109.27
317
362.34
453.8
411.29
300.28
484.24
150.12
EPS
8.59
24.91
14.23
17.83
16.16
11.8
12.79
4.69
Actual EPS
8.59
24.91
14.23
17.83
16.16
11.8
12.79
4.69
Adjusted EPS
4.3
12.46
14.23
17.83
16.16
11.8
12.79
4.69
Diluted EPS
8.59
24.91
14.23
17.83
16.16
11.8
12.68
4.68

Cohance Lifesciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
50.4
406.92
382.55
330
457.2
358.48
673.35
368.32
Cash Flow from Investing Activities
-65.48
-413.46
-311.41
-136.21
-195.01
-362.26
-387.62
-250.68
Cash Flow from Financing Activities
25.97
7.33
-75.67
-156.42
-241.96
-13.8
-327.4
-165.15
Net Cash Flow
10.9
0.79
-4.51
37.38
20.24
-17.57
-41.67
-47.51

Cohance Lifesciences Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
May 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Promoters
60%
50.1%
50.1%
50.1%
50.1%
50.1%
66.41%
66.41%
57.49%
57.49%
57.49%
57.49%
57.48%
DII
15.94%
17.24%
17.42%
16.94%
16.68%
16.6%
11.02%
11.4%
20.82%
21.57%
21.79%
20.09%
18.86%
FII
10.14%
9.54%
9.8%
10.7%
10.84%
11.05%
7.38%
7.23%
6.51%
6.02%
5.59%
6.5%
7.71%
Government
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0%
Public
13.91%
23.1%
22.67%
22.25%
22.37%
22.23%
15.18%
14.95%
15.17%
14.92%
15.12%
15.92%
15.95%
Total Outstanding Shares
25,45,64,956
25,45,64,956
25,45,64,956
25,45,64,956
25,45,64,956
25,45,64,956
38,25,67,140
38,25,67,140
38,25,67,140
38,25,67,140
38,25,67,140
38,25,67,140
38,25,97,330
Total Shareholders
70,052
68,932
65,777
69,337
84,210
86,325
88,658
80,910
75,284
81,877
85,230
99,149
93,846

Indices Featuring Cohance Lifesciences Stock

Check stock indices that include Cohance Lifesciences.

BSE Healthcare

₹48,909.83

+1,088.40 (▲2.28%)

S&P BSE 250 SmallCap

₹6,631.10

+129.85 (▲2.00%)

BSE 500

₹34,024.89

+202.75 (▲0.60%)

Nifty 500

₹21,734.90

+126.15 (▲0.58%)

Nifty MidSmallcap 400

₹19,542.30

+262.85 (▲1.36%)

Nifty Smallcap 250

₹16,933.70

+363.20 (▲2.19%)

S&P BSE 400 MidSmallCap

₹11,651.31

+156.99 (▲1.37%)

Nifty Small 100

₹18,468.70

+483.70 (▲2.69%)

Insights on Cohance Lifesciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 6.50% to 7.71% in Sep 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, COHANCE stock has moved up by 0.4%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 15.92% to 15.95% in Sep 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Divis Laboratories Ltd has given 165.2% return, outperforming this stock by 183.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 39.5% return, outperforming this stock by 84.9%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 74.08 Cr → -24.12 Cr (in ₹), with an average decrease of 106.9% per quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 18.21% to 16.93% in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 57.49% to 57.48% in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 617.28 Cr → 434.51 Cr (in ₹), with an average decrease of 29.6% per quarter

About Cohance Lifesciences Ltd

Suven Pharmaceuticals Limited (SPL) is a biopharmaceutical company engaged in the development and manufacturing of New Chemical Entity (NCE) based Intermediates and Active Pharmaceutical Ingredients, Speciality Chemicals, and formulated drugs. In 2019, Suven Life Sciences Ltd. transferred the CRAMS business to the Company, and the equity shares of the Company were listed for trading in March 2020. The Board approved and recommended the issue of 1:1 bonus shares in August 2020, and the number of shares increased from 127,282,478 to 254,564,956. In 2021, Suven invested 120 crore in investing and has a capex plan of Rs.320crore. In 2022, the Company also filed 17 ANDAs for which 9 were approved and 8 products were launched. The Company acquired 100 stake in Casper Pharma Private Limited in 2022, making it a Wholly Owned Subsidiary. In this way, Suven Pharmaceuticals Limited is endeavouring to be the leading biopharmaceutical company in global markets.

Revenue: ₹422.26Cr as on June 2026 (Q1 FY27)
Net Profit: ₹-45.19Cr as on June 2026 (Q1 FY27)
Listing date: 05 Mar, 2020
Chairperson Name: Annaswamy Vaidheesh
OrganisationCohance Lifesciences Ltd
IndustryPharmaceuticals
CEOAnnaswamy Vaidheesh
E-voting on sharesClick here to vote

FAQs

What is Cohance Lifesciences share price today?

Cohance Lifesciences share price today stands at ₹479.25 as on at the close of the market. Cohance Lifesciences share today touched a day high of ₹483.7 and a low of ₹460.55.

What is the 52 week high and 52 week low range for Cohance Lifesciences share?

Cohance Lifesciences touched a 52 week high of ₹903.4 and a 52 week low of ₹266.7. Cohance Lifesciences share price today i.e. is closed at ₹479.25, which is -46.95% down from its 52 week high and 79.70% up from its 52 week low.

What is Cohance Lifesciences's market capitalisation today?

Cohance Lifesciences market capitalisation is ₹17,735.30 Cr as on .

How to buy Cohance Lifesciences shares?

To buy Cohance Lifesciences shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for COHANCE or Cohance Lifesciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Cohance Lifesciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Cohance Lifesciences trading volume today?

Cohance Lifesciences trading volume is 12.28L as on . This means that 12.28L shares of Cohance Lifesciences were bought and sold on the stock market during today's trading session.